Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyle J Eastman

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of the American Chemical Society|September 21, 2006
Studies on the mechanism of action of prekinamycin, a member of the diazoparaquinone family of natural products: evidence for both sp2 radical and orthoquinonemethide intermediatesKen S Feldman, Kyle J Eastman
Journal of the American Chemical Society|November 3, 2005
A proposal for the mechanism-of-action of diazoparaquinone natural productsKen S Feldman, Kyle J Eastman
Organic Letters|September 27, 2002
Diazonamide synthesis studies: use of Negishi coupling to fashion diazonamide-related biaryls with defined axial chiralityKen S Feldman, Kyle J Eastman, Guillaume Lessene
Journal of the American Chemical Society|April 30, 2010
Scalable total syntheses of N-linked tryptamine dimers by direct indole-aniline coupling: psychotrimine and kapakahines B and FTimothy Newhouse, Chad A Lewis, Kyle J Eastman, et al.
Journal of Medicinal Chemistry|July 23, 2015
Applications of Fluorine in Medicinal ChemistryEric P Gillis, Kyle J Eastman, Matthew D Hill, et al.
Bioorganic & Medicinal Chemistry Letters|March 25, 2014
Identification of a novel series of potent HCV NS5B Site I inhibitorsKyle J Eastman, Zhong Yang, John A Bender, et al.
Bioorganic & Medicinal Chemistry Letters|October 7, 2018
Ferrocene-based inhibitors of hepatitis C virus replication that target NS5A with low picomolar in vitro antiviral activityVenkat R Gadhachanda, Kyle J Eastman, Qiuping Wang, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 29, 2017
Bioactivation of cyclopropyl rings by P450: an observation encountered during the optimisation of a series of hepatitis C virus NS5B inhibitorsXiaoliang Zhuo, Ying-Zi Wang, Kap-Sun Yeung, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 11, 2016
Phosphocholine conjugation: an unexpected in vivo conjugation pathway associated with hepatitis c ns5b inhibitors featuring a bicyclo[1.1.1]pentaneXiaoliang Zhuo, Joseph L Cantone, Yingzi Wang, et al.
Medchemcomm|August 16, 2018
The discovery of a pan-genotypic, primer grip inhibitor of HCV NS5B polymeraseKyle J Eastman, Kyle Parcella, Kap-Sun Yeung, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of the American Chemical Society|September 21, 2006
Studies on the mechanism of action of prekinamycin, a member of the diazoparaquinone family of natural products: evidence for both sp2 radical and orthoquinonemethide intermediatesKen S Feldman, Kyle J Eastman
Journal of the American Chemical Society|November 3, 2005
A proposal for the mechanism-of-action of diazoparaquinone natural productsKen S Feldman, Kyle J Eastman
Organic Letters|September 27, 2002
Diazonamide synthesis studies: use of Negishi coupling to fashion diazonamide-related biaryls with defined axial chiralityKen S Feldman, Kyle J Eastman, Guillaume Lessene
Journal of the American Chemical Society|April 30, 2010
Scalable total syntheses of N-linked tryptamine dimers by direct indole-aniline coupling: psychotrimine and kapakahines B and FTimothy Newhouse, Chad A Lewis, Kyle J Eastman, et al.
Journal of Medicinal Chemistry|July 23, 2015
Applications of Fluorine in Medicinal ChemistryEric P Gillis, Kyle J Eastman, Matthew D Hill, et al.
Bioorganic & Medicinal Chemistry Letters|March 25, 2014
Identification of a novel series of potent HCV NS5B Site I inhibitorsKyle J Eastman, Zhong Yang, John A Bender, et al.
Bioorganic & Medicinal Chemistry Letters|October 7, 2018
Ferrocene-based inhibitors of hepatitis C virus replication that target NS5A with low picomolar in vitro antiviral activityVenkat R Gadhachanda, Kyle J Eastman, Qiuping Wang, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 29, 2017
Bioactivation of cyclopropyl rings by P450: an observation encountered during the optimisation of a series of hepatitis C virus NS5B inhibitorsXiaoliang Zhuo, Ying-Zi Wang, Kap-Sun Yeung, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 11, 2016
Phosphocholine conjugation: an unexpected in vivo conjugation pathway associated with hepatitis c ns5b inhibitors featuring a bicyclo[1.1.1]pentaneXiaoliang Zhuo, Joseph L Cantone, Yingzi Wang, et al.
Medchemcomm|August 16, 2018
The discovery of a pan-genotypic, primer grip inhibitor of HCV NS5B polymeraseKyle J Eastman, Kyle Parcella, Kap-Sun Yeung, et al.
Pageof 2